EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,872 | +4646.2% | 626 | -90.1% | 0.00% | -100.0% |
| Q4 2022 | $208 | -99.9% | 6,345 | -23.5% | 0.00% | 0.0% |
| Q3 2022 | $257,000 | -38.5% | 8,295 | -13.6% | 0.00% | -33.3% |
| Q2 2022 | $418,000 | -16.7% | 9,605 | -3.8% | 0.00% | -25.0% |
| Q1 2022 | $502,000 | +21.3% | 9,980 | +12.1% | 0.00% | +33.3% |
| Q4 2021 | $414,000 | -20.4% | 8,900 | -10.6% | 0.00% | 0.0% |
| Q3 2021 | $520,000 | +3.2% | 9,950 | -4.0% | 0.00% | 0.0% |
| Q2 2021 | $504,000 | +2.6% | 10,369 | -7.0% | 0.00% | 0.0% |
| Q1 2021 | $491,000 | -12.2% | 11,155 | -4.8% | 0.00% | -25.0% |
| Q4 2020 | $559,000 | -2.1% | 11,720 | -3.9% | 0.00% | 0.0% |
| Q3 2020 | $571,000 | +10.7% | 12,201 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $516,000 | +2.8% | 10,354 | +6.0% | 0.00% | -20.0% |
| Q1 2020 | $502,000 | -3.5% | 9,771 | +3.2% | 0.01% | +25.0% |
| Q4 2019 | $520,000 | -11.7% | 9,472 | +0.3% | 0.00% | -20.0% |
| Q3 2019 | $589,000 | +13.3% | 9,448 | -1.0% | 0.01% | +25.0% |
| Q2 2019 | $520,000 | +6.6% | 9,548 | -6.6% | 0.00% | 0.0% |
| Q1 2019 | $488,000 | +9.9% | 10,219 | -4.7% | 0.00% | 0.0% |
| Q4 2018 | $444,000 | -29.2% | 10,723 | -0.5% | 0.00% | -20.0% |
| Q3 2018 | $627,000 | -13.5% | 10,772 | +21.8% | 0.01% | 0.0% |
| Q2 2018 | $725,000 | +50.7% | 8,842 | +1.5% | 0.01% | +66.7% |
| Q1 2018 | $481,000 | -6.4% | 8,712 | +1.3% | 0.00% | 0.0% |
| Q4 2017 | $514,000 | +2.0% | 8,601 | -11.3% | 0.00% | -25.0% |
| Q3 2017 | $504,000 | -15.9% | 9,695 | +17.9% | 0.00% | 0.0% |
| Q2 2017 | $599,000 | -26.4% | 8,226 | -8.5% | 0.00% | -33.3% |
| Q1 2017 | $814,000 | +39.1% | 8,995 | +6.5% | 0.01% | +20.0% |
| Q4 2016 | $585,000 | +13.2% | 8,445 | +5.2% | 0.01% | +25.0% |
| Q3 2016 | $517,000 | – | 8,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |